The New York Times

The chipmaker’s size and significance to the A.I trade means that Jensen Huang’s admission of a relationship with a suspected Chinese spy could reverberate across Wall Street.

The request came from Senator Edward J. Markey of Massachusetts, after Google said it would not turn off artificial intelligence tools for students using its search engine.

Prosecutors accused President Santiago Peña of funneling nearly a billion dollars of government funds to the Ueno bank as its executives made reckless insider loans.

The Ogilvy ad agency and the CAA talent agency introduced a partnership to create promotions featuring digital replicas of celebrities.

Shoppers strained by high costs of living are expected to put a priority on value this season, whether they’re buying gifts or everyday items for themselves.

Among the reasons that the 95-year-old law firm fell apart was a failure to adapt to the eat-or-be-eaten ethos of Big Law.

A federal indictment alleges that three men used generative A.I. to impersonate voices of chief executives and lawyers to defraud companies of millions of dollars.

The secretary of state’s role in drafting a secret memo highlights how top officials were concerned by last spring about Jensen Huang’s relationship with a woman tied to Chinese intelligence.

The shock to global oil prices has caused a surge in demand for electric vehicles while propelling a race for immediate, secure power supplies.

Initiative 86, which bars the force-feeding of birds and the sale of foie gras, passed handily but restaurateurs and prominent chefs are preparing for a fight.

When you sign up for the retiree health plan, the two options can present a financial puzzle. But cost is just one factor.

Sony is building an anime empire, betting that global fandom can fuel growth for both the company and the country as foreign rivals and A.I. swarm the scene.

Nintendo’s “Legend of Zelda: Ocarina of Time” was released in 1998. Now, its remake has some fans giddily reliving their childhoods.

By every measure, the drugs were no better than placebos, full data revealed on Saturday. Was it the fault of the design of the studies, or our very hypotheses about heart disease?